Xeljanz XR 11 MG tablet UU 30S

Ended Awarded

Contract number
SPE2DB25FAVBN
Awardee
Awarding agency
Obligated
$17,895

Award facts

Contract value 100% obligated
$17,895.04 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $17,895.04, is for the delivery of XELJANZ XR 11 MG TABLET with an ultimate completion date of April 21, 2025. This award is under a larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999, which allows the agency to issue firm fixed-price delivery orders for a range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract SPE2DB25FAVBN?

SPE2DB25FAVBN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 18, 2025.

How much is contract SPE2DB25FAVBN worth?

The government has obligated $17,895 on SPE2DB25FAVBN.

Is contract SPE2DB25FAVBN an order under another contract?

Yes. SPE2DB25FAVBN is a delivery order under SPE2DB24D2106, an indefinite delivery contract.

Was contract SPE2DB25FAVBN competed?

The extent of competition for SPE2DB25FAVBN was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award